The PI3K/AKT/mTOR and CDK4/6 Pathways in Endocrine Resistant HR+/HER2− Metastatic Breast Cancer: Biological Mechanisms and New Treatments

by Daniele Presti, Erica Quaquarini
Published 2019-08-01

Role of androgen receptor expression in early stage ER+/PgR−/HER2– breast cancer

by Barbara Tagliaferri, Erica Quaquarini, Raffaella Palumbo, Emanuela Balletti, Daniele Presti, Alberto Malovini, Manuela Agozzino, Cristina Maria Teragni, Andrea Terzoni, Antonio Bernardo, Laura Villani, Federico Sottotetti
Published 2020-09-01

Impact of COVID-19 Outbreak on Cancer Patient Care and Treatment: Data from an Outpatient Oncology Clinic in Lombardy (Italy)

by Erica Quaquarini, Giuseppe Saltalamacchia, Daniele Presti, Giulia Caldana, Valentina Tibollo, Alberto Malovini, Raffaella Palumbo, Cristina Maria Teragni, Emanuela Balletti, Ludovica Mollica, Elisa Biscaldi, Mara Frascaroli, Antonio Bernardo, Federico Sottotetti
Published 2020-10-01

Patterns of treatment and outcome of palbociclib plus endocrine therapy in hormone receptor-positive/HER2 receptor-negative metastatic breast cancer: a real-world multicentre Itali...

by Raffaella Palumbo, Rosalba Torrisi, Federico Sottotetti, Daniele Presti, Anna Rita Gambaro, Elena Collovà, Antonella Ferzi, Elisa Agostinetto, Cristina Maria Teragni, Giuseppe Saltalamacchia, Barbara Tagliaferri, Emanuela Balletti, Antonio Bernardo, Erica Quaquarini
Published 2021-03-01